« Older Entries

S&P 500 Rallies As U.S. Dollar Pulls Back Towards Weekly Lows

Key Insights
The strong pullback in the U.S. dollar provided significant support to stocks.
Treasury yields have pulled back after touching new highs, which served as an additional positive catalyst for S&P 500.
A move above 3730 will push S&P 500 towards the resistance level at 3760.
Advertisement

Pfizer Rallies After Announcing A Huge Price Hike For Its COVID-19 Vaccines
S&P 500 is currently trying to settle above 3730 as traders’ appetite for risk is growing. The U.S. dollar has recently gained strong downside momentum as the BoJ intervened to stop the rally in USD/JPY. Weaker U.S. dollar is bullish for stocks as it increases profits of multinational companies and makes U.S. equities cheaper for foreign investors.

The leading oil services company Schlumberger is up by 9% after beating analyst estimates on both earnings and revenue. Schlumberger’s peers Baker Hughes and Halliburton have also enjoyed strong support today.

Vaccine makers Pfizer and Moderna gained strong upside momentum after Pfizer announced that it will raise the price of its coronavirus vaccine to $110 – $130 per shot.

Biggest losers today include Verizon and Twitter. Verizon is down by 5% despite beating analyst estimates on both earnings and revenue. Subscriber numbers missed estimates, and traders pushed the stock to multi-year lows.

Twitter stock moved towards the $50 level as the U.S. may conduct a security review of Musk’s purchase of the company.

From a big picture point of view, today’s rebound is broad, and most market segments are moving higher. Treasury yields have started to move lower after testing new highs, providing additional support to S&P 500. It looks that some traders are ready to bet that Fed will be less hawkish than previously expected.

S&P 500 Tests Resistance At 3730

S&P 500 has recently managed to get above the 20 EMA and is trying to settle above the resistance at 3730. RSI is in the moderate territory, and there is plenty of room to gain additional upside momentum in case the right catalysts emerge.

If S&P 500 manages to settle above 3730, it will head towards the next resistance level at 3760. A successful test of this level will push S&P 500 towards the next resistance at October highs at 3805. The 50 EMA is located in the nearby, so S&P 500 will likely face strong resistance above the 3800 level.

On the support side, the previous resistance at 3700 will likely serve as the first support level for S&P 500. In case S&P 500 declines below this level, it will move towards the next support level at 3675. A move below 3675 will push S&P 500 towards the support at 3640.

Tags:

US Markets in green on Friday; Dow 30 up over 345 points, Nasdaq Composite, S&P 500 up nearly 1%

US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 1.14%. While S&P 500 was trading at 3,701.66, up by 0.98% and Nasdaq Composite 10,690.60 was also up by 0.71 per cent

Twitter Facebook Linkedin
US Markets in green on Friday; Dow 30 up over 345 points, Nasdaq Composite, S&P 500 up nearly 1%
Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. Source: Reuters
US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 345.25 points or1.14 per cent. While S&P 500 was trading at 3,701.66, up by 35.88 points or 0.98 per cent and Nasdaq Composite 10,690.60 was also up 75.75 points or 0.71 per cent. A Reuters report said that today’s strength was on the back of a report which said the Federal Reserve will likely debate on signaling plans for a smaller interest rate hike in December, reversing declines set off by social media firms after Snap Inc’s ad warning.

Source: Comex

Nasdaq Top Gainers and Losers

Source: Nasdaq

Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. The BSE Sensex ended at 59,307.15, up by 104.25 points or 0.18 per cent from the Thursday closing level. Meanwhile, the Nifty50 index closed at 17,590.00, higher by 26.05 points or 0.15 per cent. In the 30-share Sensex, 13 stocks gained while the remaining 17 ended on the losing side. In the 50-stock Nifty50, 21 stocks advanced while 29 declined.

Are Compounding Pharmacies Safe?

Compounding pharmacies work to create pharmaceutical products which are specifically designed to fit the unique needs of each patient. They specialise in preparing and dispensing bespoke pharmaceutical products to patients who cannot or do not want to (for whatever reason) take standard, mass produced medication. Many consumers are turning to these pharmacies because they have previously had problems with standard prescription drugs.Because the compounded prescription medications that they sell are different from those that are already available on the rest of the market, some consumers may be worried about whether or not using a compounding pharmacy is safe. However, the US Food and Drug Administration (FDA) have stated that compounding is perfectly legal and ethical so long as the pharmacy is fully licensed and the pharmacist who carried out the compounding is also fully trained and licensed.Because of the potential health implications associated with all medicinal drugs, compounding pharmaceuticals is a heavily regulated business, and the FDA and individual state boards of pharmacy have introduced strict guidelines to help ensure that customers and patients using these compounding pharmacies should remain safe. All bulk drug substances that are used in these types of pharmacies should be on an approved-list of substances that it is legal and safe to compound with. Any previously marketed substances which have been proven to be ineffective or unsafe do not make the approved-list of substances suitable for compounding. Pharmacists are not supposed to compound with any substance that is not on the approved-list. Although many states do not require practices to report any newly discovered side-effects associated with compounded drugs, ethical pharmacies will voluntarily report them.The compounding pharmacy itself is also subject to strict guidelines, as well as the substances that they compound with. The pharmacy must meet high quality control standards and each individual laboratory must meet strict facility guidelines, to ensure safety and consistency in each batch of drugs produced. Pharmacies in America are regulated by individual “state boards of pharmacy”, and therefore each state has slightly different sets of regulations. It is possible to check with the board of pharmacy in your state if you are still unsure. Inspectors from the state board will carry out regular checks on licensed pharmacies and random sampling checks may be carried out on batches of drugs that are being dispensed to check the safety and potency.Pharmacists who practice in compounding pharmacies are heavily regulated as well. They must be fully trained and licensed in order to dispense medicine that they have compounded, so that they are able to fully understand the drugs that they are making.If you still have doubts, you can contact your chosen pharmacy and they will be able to explain the standards, testing and quality control exercises that are used by their practice in order to ensure the safety of their customers. If you are in any doubt, you do not have to use that pharmacy. Remember that it is the interest of pharmacies to ensure that their products are safe, legal, ethical and effective.